Basic Information
RNALocate ID: | RLID:11002362 |
RNA Symbol: | hsa-miR-299-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-299-3p |
RNA ID: | miRBase:MIMAT0000687 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23382797 |
Tissue/Cell Line: | Brain tissue |
Method: | Microarray |
Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11002361 | Exosome | Serum | 18589210 |
RLID:11002363 | Exosome | Plasma | 23663360 |
RLID-D:11000111 | Exosome | Endothelial cells | |
RLID-D:11000399 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-299-3p | Splenic marginal zone lymphoma | MNDR-E-MI-34519 |
MNDR | hsa-miR-299-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-34520 |
MNDR | hsa-miR-299-3p | Lymphoma | MNDR-E-MI-34521 |
MNDR | hsa-miR-299-3p | Lymphoma non-hodgkin | MNDR-E-MI-34522 |
MNDR | hsa-miR-299-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34523 |
MNDR | hsa-miR-299-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34524 |
MNDR | hsa-miR-299-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34525 |
MNDR | hsa-miR-299-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34526 |
MNDR | hsa-miR-299-3p | Her2-receptor positive breast cancer | MNDR-E-MI-34527 |
MNDR | hsa-miR-299-3p | Breast cancer luminal | MNDR-E-MI-34528 |
MNDR | hsa-miR-299-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-34529 |
MNDR | hsa-miR-299-3p | Gastric cancer | MNDR-E-MI-34530 |
MNDR | hsa-miR-299-3p | Alzheimer disease | MNDR-E-MI-34531 |
MNDR | hsa-miR-299-3p | Duchenne muscular dystrophy | MNDR-E-MI-34532 |
MNDR | hsa-miR-299-3p | Head and neck cancer | MNDR-E-MI-34533 |
MNDR | hsa-miR-299-3p | Lung cancer | MNDR-E-MI-34534 |
MNDR | hsa-miR-299-3p | Parkinson disease | MNDR-E-MI-34535 |
MNDR | hsa-miR-299-3p | Colon carcinoma | MNDR-E-MI-34536 |
MNDR | hsa-miR-299-3p | Breast cancer | MNDR-E-MI-34537 |
MNDR | hsa-miR-299-3p | Neuroendocrine neoplasia | MNDR-E-MI-34538 |
MNDR | hsa-miR-299-3p | Pancreatic cancer | MNDR-E-MI-34539 |
MNDR | hsa-miR-299-3p | Melanoma | MNDR-E-MI-34540 |
MNDR | hsa-miR-299-3p | Nephroblastoma | MNDR-E-MI-34541 |
MNDR | hsa-miR-299-3p | West nile virus infection | MNDR-E-MI-34542 |
MNDR | hsa-miR-299-3p | Ovarian cancer | MNDR-E-MI-34543 |
MNDR | hsa-miR-299-3p | Prostate adenocarcinoma | MNDR-E-MI-34544 |
MNDR | hsa-miR-299-3p | Glioblastoma | MNDR-E-MI-34545 |
MNDR | hsa-miR-299-3p | Glioma | MNDR-E-MI-34546 |
MNDR | hsa-miR-299-3p | Nemaline myopathy | MNDR-E-MI-34547 |
MNDR | hsa-miR-299-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-34548 |
MNDR | hsa-miR-299-3p | Temporal lobe epilepsy | MNDR-E-MI-34549 |
MNDR | hsa-miR-299-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-34550 |
MNDR | hsa-miR-299-3p | Uterine cancer | MNDR-E-MI-34551 |
MNDR | hsa-miR-299-3p | Cervical squamous cell carcinoma | MNDR-E-MI-34552 |
MNDR | hsa-miR-299-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-34553 |
MNDR | hsa-miR-299-3p | Lung squamous cell carcinoma | MNDR-E-MI-34554 |
MNDR | hsa-miR-299-3p | Ovarian carcinoma | MNDR-E-MI-34555 |
MNDR | hsa-miR-299-3p | Bladder urothelial carcinoma | MNDR-E-MI-34556 |
MNDR | hsa-miR-299-3p | Pancreatic adenocarcinoma | MNDR-E-MI-34557 |
MNDR | hsa-miR-299-3p | Cholangiocarcinoma | MNDR-E-MI-34558 |
MNDR | hsa-miR-299-3p | Synovial sarcoma | MNDR-E-MI-34559 |
MNDR | hsa-miR-299-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-34560 |
MNDR | hsa-miR-299-3p | Hepatocellular carcinoma | MNDR-E-MI-34561 |
MNDR | hsa-miR-299-3p | Lymphoblastoid | MNDR-E-MI-34562 |
MNDR | hsa-miR-299-3p | Retinoblastoma | MNDR-E-MI-34563 |
MNDR | hsa-miR-299-3p | Barrett's adenocarcinoma | MNDR-E-MI-34564 |
MNDR | hsa-miR-299-3p | Burkitt lymphoma | MNDR-E-MI-34565 |
MNDR | hsa-miR-299-3p | Tonsil cancer | MNDR-E-MI-34566 |
MNDR | hsa-miR-299-3p | Colorectal cancer | MNDR-E-MI-34567 |
MNDR | hsa-miR-299-3p | Multiple myeloma | MNDR-E-MI-34568 |
MNDR | hsa-miR-299-3p | Acute lymphocytic leukemia | MNDR-E-MI-34569 |
MNDR | hsa-miR-299-3p | Stroke lacunar | MNDR-E-MI-34570 |
MNDR | hsa-miR-299-3p | Barrett's carcinogenesis | MNDR-E-MI-34571 |
MNDR | hsa-miR-299-3p | Breast cancer her3+ negative | MNDR-E-MI-34572 |
MNDR | hsa-miR-299-3p | HPV | MNDR-E-MI-34573 |
MNDR | hsa-miR-299-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-34574 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCE1 | Homo sapiens | RR00024335 |
TOP